Recent Patents on Anti-Cancer Drug Discovery

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:14   Issue: 3
Pp: 201-201
Anna Sapino
DOI: 10.2174/157489281403191028142655



Safety Profiles and Pharmacovigilance Considerations for Recently Patented / Approved Anticancer Drugs free to download

Volume:14   Issue: 3
Pp: 202-202
Paolo Baldo
DOI: 10.2174/157489281403191028143024



Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma

Volume:14   Issue: 3
Pp: 203-225
Debora Basile, Camilla Lisanti, Maria A. Pizzichetta, Paolo Baldo*, Giulia Fornasier, Francesco Lo Re, Giuseppe Corona and Fabio Puglisi
DOI: 10.2174/1574892814666190726130351



Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer

Volume:14   Issue: 3
Pp: 226-241
Emanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, Giulia Fornasier, Elisa Giacomin, Francesco Lo Re, Paolo Baldo*, Giuseppe Corona and Carlo Gobitti
DOI: 10.2174/1574892814666190726143011



Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer

Volume:14   Issue: 3
Pp: 242-257
Alessandra Bearz, Sara Cecco, Sara Francescon, Francesco Lo Re, Giuseppe Corona and Paolo Baldo*
DOI: 10.2174/1574892814666190726124735



HMGA and Cancer: A Review on Patent Literatures

Volume:14   Issue: 3
Pp: 258-267
Marco De Martino, Alfredo Fusco and Francesco Esposito*
DOI: 10.2174/1574892814666190919152001



Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma

Volume:14   Issue: 3
Pp: 268-279
Ying Liu, Zhi Li, Xinyue Tang, Min Li and Feng Shi*
DOI: 10.2174/1574892814666190919145453



Patent Selections promotion: free to download

Volume:14   Issue: 3
Pp: 292-294

DOI: 10.2174/157489281403191028143330